Enovis Corporation · Healthcare · Medical Equipment
As of 2026-06-26, Enovis Corporation (ENOV) has a 3-month relative strength percentile of 35 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 43. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.3%, relative volume 1.79×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
35 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ENOV is in a stage 4 downtrend, week 5. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -3.8% / -13.1%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
ENOV is held by 8 ETFs as of Mar 2026. Top owner: IJR at 0.08% weight, $78M notional. Top 3 carry $151M.
Top 8 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.08% | $78M |
| VTIVanguard Total Stock Market ETF | 0.00% | $41M |
| IWMiShares Russell 2000 ETF | 0.04% | $32M |
| VBVanguard Small Cap ETF | 0.02% | $30M |
| VBRVanguard Small Cap Value ETF | 0.03% | $19M |
| VXFVanguard Extended Market ETF | 0.02% | $15M |
| XHEState Street SPDR S&P Health Care Equipment ETF | 1.59% | $2M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ENOV Jan avg: 3.05% median: 5.92% win: 75% σ: 14.65% n: 4 2022-04-12 → 2026-05-29 | ENOV Feb avg: -2.19% median: -3.29% win: 50% σ: 14.29% n: 4 2022-04-12 → 2026-05-29 | ENOV Mar avg: -3.64% median: -4.15% win: 25% σ: 6.66% n: 4 2022-04-12 → 2026-05-29 | ENOV Apr avg: -2.85% median: -5.13% win: 40% σ: 8.63% n: 5 2022-04-12 → 2026-05-29 | ENOV May avg: -5.79% median: -8.98% win: 20% σ: 5.22% n: 5 2022-04-12 → 2026-05-29 | ENOV Jun avg: -1.35% median: -4.95% win: 50% σ: 16.86% n: 4 2022-04-12 → 2026-05-29 (current) | ENOV Jul avg: -0.23% median: 2.53% win: 50% σ: 10.23% n: 4 2022-04-12 → 2026-05-29 | ENOV Aug avg: -3.59% median: -7.24% win: 25% σ: 13.77% n: 4 2022-04-12 → 2026-05-29 | ENOV Sep avg: -6.09% median: -6.76% win: 0% σ: 3.13% n: 4 2022-04-12 → 2026-05-29 | ENOV Oct avg: -1.70% median: -0.58% win: 50% σ: 8.87% n: 4 2022-04-12 → 2026-05-29 | ENOV Nov avg: 8.10% median: 8.61% win: 75% σ: 8.77% n: 4 2022-04-12 → 2026-05-29 | ENOV Dec avg: -2.49% median: -5.61% win: 25% σ: 11.52% n: 4 2022-04-12 → 2026-05-29 |